About the Authors
- Joost H. C. M. Kreijtz
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Yasemin Suezer
-
Affiliation Paul-Ehrlich-Institut, Langen, Germany
- Gerrie de Mutsert
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Geert van Amerongen
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Astrid Schwantes
-
Affiliation Paul-Ehrlich-Institut, Langen, Germany
- Judith M. A. van den Brand
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Ron A. M. Fouchier
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Johannes Löwer
-
Affiliation Paul-Ehrlich-Institut, Langen, Germany
- Albert D. M. E. Osterhaus
-
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
- Gerd Sutter
-
Affiliations Paul-Ehrlich-Institut, Langen, Germany, Ludwig-Maximilians-Universität, München, Germany
- Guus F. Rimmelzwaan
-
* E-mail: g.rimmelzwaan@erasmusmc.nl
Affiliation Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
Competing Interests
A patent application (PCT/EP2007/062446) on the use of MVA as candidate influenza vaccine was filed (Publication date May 29, 2008). GR has an affiliation with Viroclinics BV as a consultant.
Author Contributions
Conceived and designed the experiments: JK GS GFR. Performed the experiments: JK YS GdM GvA AS. Analyzed the data: JK JvdB GS GFR. Contributed reagents/materials/analysis tools: YS AS. Wrote the paper: JK RAMF JL ADMEO GS GFR.